Thrombocytopenic c-mpl-/- mice can produce a normal level of platelets after administration of 5-fluorouracil:: the effect of age on the response

被引:35
作者
Levin, J
Cocault, L
Demerens, C
Challier, C
Pauchard, M
Caen, J
Souyri, M
机构
[1] Hop Paul Brousse, INSERM U506, F-94807 Villejuif, France
[2] Inst Vaisseaux & Sang, Paris, France
[3] Hop Cochin, INSERM U363, F-75674 Paris, France
关键词
D O I
10.1182/blood.V98.4.1019
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Administration of 5-fluorouracil (5-FU) to mice results in a marked increase in the level of circulating platelets in 10 days. Mice lacking Mpl, the receptor for thrombopoietin (TPO), are thrombocytopenic. To gain insight into the mechanism by which 5-FU produces such a substantial stimulation of platelet production, this study investigated whether 5-FU (150 mg/kg) produced thrombocytosis in c-mpl(-/-)mice, thus establishing whether TPO was required for this response. A 5- to 6-fold increase in platelet levels in c-mpl(-/-) mice (to approximately 1000 x 10(9)/L) was observed on days 20 and 25 after 5-FU injection. Thus, at the peak of the response, c-mpl(-/-) mice had platelet levels comparable to those in normal mice. Administration of 5-FU also produced thrombocytosis in previously splenectomized c-mpl(-/-) mice. Comparison of the platelet response to 5-FU in young (6-12 weeks) and old (33-46 weeks) c-mpl(-/-) mice found that older mice produced a much more marked response than younger mice, with a mean maximum platelet level of approximately 1700 x 10(9)/L. To determine whether this increase in circulating platelets was preceded by an increase in hematopoietic progenitors, serial cultures of bone marrow and spleen were evaluated. A considerable increase in all colony types studied was observed on days 15 and 20 in spleens of c-mpl(-/-) mice, but no similar elevations were detected in bone marrow. These results indicate that c-mpl(-/-) mice can achieve a normal level of platelets after 5-FU injection, by means of a TPO-independent mechanism, and that they respond to 5-FU myelosuppression by producing large numbers of megakaryocytic, myeloid, and erythroid progenitors.
引用
收藏
页码:1019 / 1027
页数:9
相关论文
共 55 条
[1]   Deficiencies in progenitor cells of multiple hematopoietic lineages and defective megakaryocytopoiesis in mice lacking the thrombopoietin receptor c-mpl [J].
Alexander, WS ;
Roberts, AW ;
Nicola, NA ;
Li, RL ;
Metcalf, D .
BLOOD, 1996, 87 (06) :2162-2170
[2]  
ARNOLD J, 1991, EXP HEMATOL, V19, P24
[3]  
ARNOLD JT, 1995, EXP HEMATOL, V23, P161
[4]   A single injection of pegylated murine megakaryocyte growth and development factor (MGDF) into mice is sufficient to produce a profound stimulation of megakaryocyte frequency, size, and ploidization [J].
Arnold, JT ;
Daw, NC ;
Stenberg, PE ;
Jayawardene, D ;
Srivastava, DK ;
Jackson, CW .
BLOOD, 1997, 89 (03) :823-833
[5]   Transient thrombocytopenia produced by administration of macrophage colony-stimulating factor: Investigations of the mechanism [J].
Baker, GR ;
Levin, J .
BLOOD, 1998, 91 (01) :89-99
[6]   P-selectin and platelet clearance [J].
Berger, G ;
Hartwell, DW ;
Wagner, DD .
BLOOD, 1998, 92 (11) :4446-4452
[7]   THROMBOPOIETIN (C-MPL LIGAND) ACTS SYNERGISTICALLY WITH ERYTHROPOIETIN, STEM-CELL FACTOR, AND INTERLEUKIN-11 TO ENHANCE MURINE MEGAKARYOCYTE COLONY GROWTH AND INCREASES MEGAKARYOCYTE PLOIDY IN-VITRO [J].
BROUDY, VC ;
LIN, NL ;
KAUSHANSKY, K .
BLOOD, 1995, 85 (07) :1719-1726
[8]   Regulation of c-Jun-NH2 terminal kinase and extracellular-signal regulated kinase in human platelets [J].
Bugaud, F ;
Nadal-Wollbold, F ;
Lévy-Toledano, S ;
Rosa, JP ;
Bryckaert, M .
BLOOD, 1999, 94 (11) :3800-3805
[9]   Normal platelets and megakaryocytes are produced in vivo in the absence of thrombopoietin [J].
Bunting, S ;
Widmer, R ;
Lipari, TR ;
Rangell, L ;
Steinmetz, H ;
CarverMoore, K ;
Moore, MW ;
Keller, GA ;
deSauvage, FJ .
BLOOD, 1997, 90 (09) :3423-3429
[10]  
CarverMoore K, 1996, BLOOD, V88, P803